- Home
- IMMX vs ZDGE Comparison
IMMX vs ZDGE Comparison
Compare IMMX & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- ZDGE
- Stock Information
- Founded
- IMMX 2014
- ZDGE 2008
- Country
- IMMX United States
- ZDGE United States
- Employees
- IMMX N/A
- ZDGE N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- ZDGE Computer Software: Prepackaged Software
- Sector
- IMMX Health Care
- ZDGE Technology
- Exchange
- IMMX Nasdaq
- ZDGE Nasdaq
- Market Cap
- IMMX 51.1M
- ZDGE 51.8M
- IPO Year
- IMMX 2021
- ZDGE N/A
- Fundamental
- Price
- IMMX $1.78
- ZDGE $3.61
- Analyst Decision
- IMMX Strong Buy
- ZDGE
- Analyst Count
- IMMX 1
- ZDGE 0
- Target Price
- IMMX $7.00
- ZDGE N/A
- AVG Volume (30 Days)
- IMMX 125.2K
- ZDGE 47.6K
- Earning Date
- IMMX 11-11-2024
- ZDGE 10-24-2024
- Dividend Yield
- IMMX N/A
- ZDGE N/A
- EPS Growth
- IMMX N/A
- ZDGE N/A
- EPS
- IMMX N/A
- ZDGE N/A
- Revenue
- IMMX N/A
- ZDGE $29,142,000.00
- Revenue This Year
- IMMX N/A
- ZDGE $13.67
- Revenue Next Year
- IMMX $200.00
- ZDGE $13.41
- P/E Ratio
- IMMX N/A
- ZDGE N/A
- Revenue Growth
- IMMX N/A
- ZDGE 4.15
- 52 Week Low
- IMMX $1.26
- ZDGE $1.70
- 52 Week High
- IMMX $7.75
- ZDGE $5.18
- Technical
- Relative Strength Index (RSI)
- IMMX 52.09
- ZDGE 58.17
- Support Level
- IMMX $1.26
- ZDGE $3.55
- Resistance Level
- IMMX $1.94
- ZDGE $3.75
- Average True Range (ATR)
- IMMX 0.13
- ZDGE 0.20
- MACD
- IMMX 0.01
- ZDGE 0.05
- Stochastic Oscillator
- IMMX 83.87
- ZDGE 80.07
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.